Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Systemic Biodistribution and Intravitreal Pharmacokinetic Properties of Bevacizumab, Ranibizumab, and Aflibercept in a Nonhuman Primate Model.

Christoforidis JB, Briley K, Binzel K, Bhatia P, Wei L, Kumar K, Knopp MV.

Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5636-5645. doi: 10.1167/iovs.17-22431.

PMID:
29094168
2.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Ocular Melanoma as a Tool to Predict Metastatic Potential.

Wei W, Jia G, von Tengg-Kobligk H, Heverhagen JT, Abdel-Rahman M, Wei L, Christoforidis JB, Davidorf F, Knopp MV.

J Comput Assist Tomogr. 2017 Sep/Oct;41(5):823-827. doi: 10.1097/RCT.0000000000000598.

3.

Epiretinal membrane: optical coherence tomography-based diagnosis and classification.

Stevenson W, Prospero Ponce CM, Agarwal DR, Gelman R, Christoforidis JB.

Clin Ophthalmol. 2016 Mar 29;10:527-34. doi: 10.2147/OPTH.S97722. eCollection 2016. Review.

4.

Ocriplasmin: who is the best candidate?

Prospero Ponce CM, Stevenson W, Gelman R, Agarwal DR, Christoforidis JB.

Clin Ophthalmol. 2016 Mar 17;10:485-95. doi: 10.2147/OPTH.S97947. eCollection 2016. Review.

5.

Retinal Damage Induced by Internal Limiting Membrane Removal.

Gelman R, Stevenson W, Prospero Ponce C, Agarwal D, Christoforidis JB.

J Ophthalmol. 2015;2015:939748. doi: 10.1155/2015/939748. Epub 2015 Sep 3. Review.

6.

The Vitreomacular Interface in Diabetic Retinopathy.

Agarwal D, Gelman R, Prospero Ponce C, Stevenson W, Christoforidis JB.

J Ophthalmol. 2015;2015:392983. doi: 10.1155/2015/392983. Epub 2015 Sep 3. Review.

7.

Vitreomacular Interface: From Anterior to Tangential Traction.

Romano MR, Valldeperas X, Christoforidis JB.

J Ophthalmol. 2015;2015:197513. doi: 10.1155/2015/197513. Epub 2015 Sep 6. No abstract available.

8.

Systemic treatments for noninfectious vitreous inflammation.

Jiang A, Wang J, Joshi M, Christoforidis JB.

Mediators Inflamm. 2013;2013:515312. doi: 10.1155/2013/515312. Epub 2013 Nov 20. Review.

9.

Inflammatory mechanisms of idiopathic epiretinal membrane formation.

Joshi M, Agrawal S, Christoforidis JB.

Mediators Inflamm. 2013;2013:192582. doi: 10.1155/2013/192582. Epub 2013 Nov 11. Review.

10.

Vitreous inflammation associated with intravitreal anti-VEGF pharmacotherapy.

Agrawal S, Joshi M, Christoforidis JB.

Mediators Inflamm. 2013;2013:943409. doi: 10.1155/2013/943409. Epub 2013 Nov 6. Review.

11.

Serum levels of intravitreal bevacizumab after vitrectomy, lensectomy and non-surgical controls.

Christoforidis JB, Xie Z, Jiang A, Wang J, Pratt C, Gemensky-Metzler A, Abdel-Rasoul M, Roy S, Liu Z.

Curr Eye Res. 2013 Jul;38(7):761-6. doi: 10.3109/02713683.2013.763988. Epub 2013 Apr 2.

12.

Anatomic and pharmacokinetic properties of intravitreal bevacizumab and ranibizumab after vitrectomy and lensectomy.

Christoforidis JB, Williams MM, Wang J, Jiang A, Pratt C, Abdel-Rasoul M, Hinkle GH, Knopp MV.

Retina. 2013 May;33(5):946-52. doi: 10.1097/IAE.0b013e3182753b12.

13.

The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing.

Christoforidis JB, Wang J, Jiang A, Willard J, Pratt C, Abdel-Rasoul M, Roy S, Powell H.

Clin Ophthalmol. 2013;7:185-91. doi: 10.2147/OPTH.S40537. Epub 2013 Jan 24.

14.

Subconjunctival bleb that forms at the injection site after intravitreal injection is drug, not vitreous.

Christoforidis JB, Williams MM, Epitropoulos FM, Knopp MV.

Clin Exp Ophthalmol. 2013 Aug;41(6):614-5. doi: 10.1111/ceo.12074. No abstract available.

PMID:
23331405
15.

Systemic treatment of vitreous inflammation.

Christoforidis JB, Chang S, Jiang A, Wang J, Cebulla CM.

Mediators Inflamm. 2012;2012:936721. doi: 10.1155/2012/936721. Epub 2012 Sep 16. Review.

16.

Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT.

Christoforidis JB, Williams MM, Kothandaraman S, Kumar K, Epitropoulos FJ, Knopp MV.

Curr Eye Res. 2012 Dec;37(12):1171-4. doi: 10.3109/02713683.2012.727521. Epub 2012 Sep 19.

PMID:
22991959
17.

Intravitreal devices for the treatment of vitreous inflammation.

Christoforidis JB, Chang S, Jiang A, Wang J, Cebulla CM.

Mediators Inflamm. 2012;2012:126463. doi: 10.1155/2012/126463. Epub 2012 Sep 5. Review.

18.

Retrobulbar vasculature using 7-T magnetic resonance imaging with dedicated eye surface coil.

Christoforidis JB, Wassenaar PA, Christoforidis GA, Ho VY, Knopp MV, Schmalbrock PM.

Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):271-7. doi: 10.1007/s00417-012-2154-x. Epub 2012 Sep 16.

PMID:
22983487
19.

Histopathology of optic nerve pit-associated maculopathy.

Christoforidis JB, Terrell W, Davidorf FH.

Clin Ophthalmol. 2012;6:1169-74. doi: 10.2147/OPTH.S34706. Epub 2012 Jul 25.

20.
21.

PET/CT imaging of I-124-radiolabeled bevacizumab and ranibizumab after intravitreal injection in a rabbit model.

Christoforidis JB, Carlton MM, Knopp MV, Hinkle GH.

Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5899-903. doi: 10.1167/iovs.10-6862.

PMID:
21685343
22.

Volume of visual field assessed with kinetic perimetry and its application to static perimetry.

Christoforidis JB.

Clin Ophthalmol. 2011;5:535-41. doi: 10.2147/OPTH.S18815. Epub 2011 Apr 26.

23.

Age related macular degeneration and visual disability.

Christoforidis JB, Tecce N, Dell'Omo R, Mastropasqua R, Verolino M, Costagliola C.

Curr Drug Targets. 2011 Feb;12(2):221-33.

PMID:
20887239
24.

Histology of retina overlying bacterial subretinal abscess and implications for treatment.

Christoforidis JB, Warden SM, Farrell GM, Baker M, Mukai S.

Retin Cases Brief Rep. 2007 Fall;1(4):257-60. doi: 10.1097/01.iae.0000238381.27024.d1.

PMID:
25390996
25.

Choroidal neovascularization after epiretinal membrane removal.

Warden SM, Pachydaki SI, Christoforidis JB, D'Amico DJ, Loewenstein JI.

Arch Ophthalmol. 2006 Nov;124(11):1652-4. No abstract available.

PMID:
17102017
26.

In vivo redirection of retinal blood flow into borosilicate micro-cannulas in rabbits.

Christoforidis JB, Warden SM, Demattia M, D'Amico DJ.

Graefes Arch Clin Exp Ophthalmol. 2006 Aug;244(8):1022-5. Epub 2006 Jan 18.

PMID:
16418840
27.
28.

In vivo rabbit eyecup preparation for use in retinal research.

Tsilimbaris M, Lit ES, Christoforidis JB, D'Amico DJ.

Invest Ophthalmol Vis Sci. 2004 Mar;45(3):906-9.

PMID:
14985309
29.

Surgical and other treatments of diabetic macular edema: an update.

Christoforidis JB, D'Amico DJ.

Int Ophthalmol Clin. 2004 Winter;44(1):139-60. Review. No abstract available.

PMID:
14704528
30.

CT characteristics of intraocular perfluoro-N-octane.

Christoforidis JB, Caruso PA, Curtin HD, Fiore T, D'Amico DJ.

AJNR Am J Neuroradiol. 2003 Oct;24(9):1769-71.

31.

Resolution of leukemic retinopathy following treatment with imatinib mesylate for chronic myelogenous leukemia.

Christoforidis JB, DeAngelo DJ, D'Amico DJ.

Am J Ophthalmol. 2003 Mar;135(3):398-400.

PMID:
12614767

Supplemental Content

Loading ...
Support Center